Skip Navigation

PANOVA-3: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields Ttfields, 150khz Concomitant with Gemcitabine and Nab-Paclitaxel for Front-Line Treatment of Locally-Advanced Pancreatic Adenocarcinoma

Brief Summary

Type:
Pancreatic

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT03377491

Study #:
STUDY00142775

Start Date:
Mar 18, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03377491

View Complete Trial Details & Eligibility at ClinicalTrials.gov